NanoViricides Inc. (NNVC)
AMEX: NNVC
· Real-Time Price · USD
1.49
0.02 (1.71%)
At close: Aug 15, 2025, 3:59 PM
1.49
0.00%
After-hours: Aug 15, 2025, 07:35 PM EDT
NanoViricides Income Statement
Financials in USD. Fiscal
year is
July - June.
Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 190.6K | 380.56K | 569.89K | 759.01K | 757.29K | 755.66K | 753.25K | 747.53K | 746.6K | 739.84K | 730.3K | 723.33K | 711.53K | 706.12K | 528.73K | 352.31K | 176.14K | n/a | n/a |
Gross Profit | -190.6K | -380.56K | -569.89K | -759.01K | -757.29K | -755.66K | -753.25K | -747.53K | -746.6K | -739.84K | -730.3K | -723.33K | -711.53K | -706.12K | -528.73K | -352.31K | -176.14K | n/a | n/a |
Operating Income | -9.87M | -9.53M | -9.65M | -8.52M | -9.8M | -9.7M | -9.35M | -8.94M | -7.06M | -7.04M | -7.12M | -8.11M | -8.4M | -8.71M | -9.09M | -8.74M | -8.5M | -8.94M | -8.28M |
Interest Income | 140.48K | 162.03K | 213.46K | 271.77K | 342.78K | 396.79K | 402.61K | 355.83K | 249.45K | 141.52K | 54.63K | 2.26K | 5.34K | 7.36K | 6.48K | 9.35K | 8.08K | 15.32K | 14.92K |
Pretax Income | -9.73M | -9.36M | -9.45M | -8.29M | -9.51M | -9.36M | -8.99M | -8.59M | -6.8M | -6.89M | -7.06M | -8.11M | -8.4M | -8.72M | -9.12M | -8.82M | -8.62M | -14.6M | -14.2M |
Net Income | -9.73M | -9.36M | -9.45M | -8.29M | -9.51M | -9.25M | -8.79M | -8.34M | -6.55M | -6.75M | -7.02M | -8.11M | -8.4M | -8.72M | -9.12M | -8.82M | -8.62M | -14.6M | -14.2M |
Selling & General & Admin | 4.31M | 3.85M | 3.37M | 2.7M | 2.25M | 2.36M | 2.61M | 2.55M | 2.41M | 2.33M | 2.32M | 2.33M | 2.2M | 2.31M | 2.45M | 2.63M | 2.9M | 3.67M | 3.49M |
Research & Development | 5.55M | 5.49M | 5.9M | 5.44M | 7.17M | 7.15M | 6.75M | 6.39M | 4.65M | 4.71M | 4.8M | 5.78M | 6.2M | 6.41M | 6.64M | 6.11M | 5.6M | 5.27M | 4.79M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 9.87M | 9.34M | 9.27M | 8.14M | 9.42M | 9.51M | 9.35M | 8.94M | 7.06M | 7.04M | 7.12M | 8.11M | 8.4M | 8.71M | 9.09M | 8.74M | 8.5M | 8.94M | 8.28M |
Interest Expense | 149.00 | 149.00 | 13.31K | 49.81K | 49.81K | 49.81K | 36.59K | 938.00 | 938.00 | 5.73K | 8.26K | 8.31K | 10K | 7.72K | 42.39K | 85.41K | 128.32K | 170.74K | 137.58K |
Selling & Marketing Expenses | n/a | -189.96K | -379.29K | -379.29K | -379.29K | -189.33K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.62M | 9.53M | 9.65M | 8.52M | 9.8M | 9.7M | 9.35M | 8.94M | 7.06M | 7.04M | 7.12M | 8.11M | 8.4M | 8.71M | 9.09M | 8.74M | 8.5M | 8.94M | 8.28M |
Income Tax Expense | n/a | 4.00 | 4.00 | 4.00 | 4.00 | -107.94K | -196.8K | -248.51K | -236.66K | -123.93K | -32.44K | 19.47K | 10.69K | 7.92K | 5.29K | 8.16K | 6.89K | 49.81K | 49.81K |
Shares Outstanding (Basic) | 16.03M | 14.57M | 13.72M | 11.87M | 11.78M | 11.75M | 11.72M | 11.7M | 11.64M | 11.61M | 11.59M | 11.56M | 11.54M | 11.53M | 11.52M | 10.95M | 10.95M | 10.67M | 10.49M |
Shares Outstanding (Diluted) | 16.03M | 14.57M | 13.72M | 11.87M | 11.78M | 11.75M | 11.72M | 11.7M | 11.64M | 11.61M | 11.59M | 11.56M | 11.54M | 11.53M | 11.52M | 10.95M | 10.95M | 10.67M | 10.49M |
EPS (Basic) | -0.71 | -0.73 | -0.77 | -0.71 | -0.82 | -0.8 | -0.76 | -0.72 | -0.56 | -0.58 | -0.61 | -0.71 | -0.75 | -0.78 | -0.83 | -0.82 | -0.81 | -1.86 | -2.14 |
EPS (Diluted) | -0.71 | -0.73 | -0.77 | -0.71 | -0.82 | -0.8 | -0.76 | -0.72 | -0.56 | -0.58 | -0.61 | -0.71 | -0.75 | -0.78 | -0.83 | -0.82 | -0.81 | -1.86 | -2.14 |
EBITDA | -9.22M | -8.63M | -8.71M | -7.49M | -8.7M | -8.55M | -8.2M | -7.84M | -6.05M | -6.14M | -6.33M | -7.38M | -7.68M | -8M | -8.38M | -8.03M | -7.79M | -13.73M | -13.36M |
EBIT | -7.51M | -9.36M | -9.44M | -8.24M | -9.46M | -9.31M | -8.95M | -8.59M | -6.8M | -6.88M | -7.06M | -8.1M | -8.39M | -8.71M | -9.08M | -8.74M | -8.5M | -14.43M | -14.06M |
Depreciation & Amortization | 582.1K | 772.05K | 765.5K | 759.01K | 757.29K | 755.66K | 753.25K | 747.53K | 746.6K | 739.84K | 730.3K | 723.33K | 711.53K | 706.12K | 703.73K | 704.54K | 703.36K | 702.15K | 702.07K |